| Dr Jason Halegoua, PHD, MD, MBA | |
|
207 Hallock Rd Ste 106, Stony Brook, NY 11790-3075 | |
| (631) 675-9777 | |
| (631) 675-9778 |
| Full Name | Dr Jason Halegoua |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 207 Hallock Rd Ste 106, Stony Brook, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013023555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 231789 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Halegoua, PHD, MD, MBA 11 Lily Dr, South Setauket, NY 11720-2001 Ph: (516) 650-3636 | Dr Jason Halegoua, PHD, MD, MBA 207 Hallock Rd Ste 106, Stony Brook, NY 11790-3075 Ph: (631) 675-9777 |
News Archive
TV infomercials offer a world of potential solutions for back pain, but most of them have at least one of three problems -; they're unproven, unworkable or just plain unattractive.
Alcon, Inc. announced today that it has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive U.S. Food and Drug Administration clearance for use as a part of cataract surgery. The LenSx system is indicated for anterior capsulotomy and laser phacofragmentation during cataract surgery, providing a complementary surgical approach to certain manual steps within the traditional cataract procedure.
Agilent Technologies Inc. today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University's Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, has received an Agilent Thought Leader Award to support his work on quantitative analysis of cellular metabolism.
Sheep gene research at the University of Adelaide's Roseworthy Campus aimed at helping maximise wool production for Australian producers, has shed light on a human genetic hair and skin disorder.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that combination therapy with epratuzumab and rituximab was effective, with durable complete responses in one-third of evaluable patients, and was very well tolerated by patients with previously untreated follicular lymphoma (FL).
› Verified 8 days ago
Dr. Mireya Garcia, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: University Hospital, L5, Stony Brook, NY 11794 Phone: 631-444-3429 | |
Dr. Christy Anne Beneri, DO Pediatrics Medicare: Accepting Medicare Assignments Practice Location: Hsc Suny Stony Brook, Department Of Pediatrics Hsc T-11, Stony Brook, NY 11794 Phone: 631-444-7992 Fax: 631-444-7292 | |
Pianpian Wu, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-5437 | |
Brittani Rose Mannix, NNP-BC Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-2000 | |
Kathleen Doobinin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Department Of Pediatrics, Hsc T-11-020, Stony Brook, NY 11794 Phone: 631-444-2710 | |
Dr. Stephanie Anne Tischler, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 Nesconset Hwy Bldg 14, Stony Brook, NY 11790 Phone: 631-689-6226 Fax: 631-675-0736 |